Bio Medica Laboratories Peer Comparison
NSE: BMLL
₹153.00
₹7.65
(5.26%)
As on 02-Sep-2026 11:02IST
Market cap
₹183 Cr
Revenue (TTM)
₹38 Cr
P/E Ratio
15.2
P/B Ratio
--
Div. Yield
0 %
Edit
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
183 | 7,869 | 133 | 133 | 39 |
Revenue (₹ Cr) |
38 | 7,128 | 107 | 58 | 31 |
Net Profit (₹ Cr) |
9.79 | 167.66 | 4.80 | 8.61 | 4.12 |
Net Margin (%) |
25.56 | 2.35 | 4.46 | 14.70 | 13.20 |
RoE (%) |
99.59 | 7.58 | 14.91 | 37.85 | 39.41 |
Price to Earnings |
15.24 | 62.75 | 26.55 | 10.18 | 9.54 |
Price-To-Book |
-- | 4.54 | -- | 1.86 | 1.63 |
Income Statement (₹ Cr)
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
|
Operating Revenue
|
38.20 | 5,095.78 | 106.81 | 58.27 | 28.06 |
|
Total Income
|
38.33 | 5,135.29 | 107.59 | 58.54 | 28.06 |
|
Total Expenditure
|
22.82 | 4,924.23 | 98.22 | 49.14 | 22.00 |
|
EBITDA
|
15.37 | 171.55 | 8.59 | 9.13 | 6.06 |
|
Depreciation
|
1.01 | 30.69 | 0.69 | 0.20 | 0.25 |
|
EBIT
|
14.37 | 140.86 | 7.90 | 8.93 | 5.81 |
|
Interest
|
1.35 | 41.62 | 2.15 | 0.51 | 1.95 |
|
Other Income
|
0.13 | 39.51 | 0.78 | 0.27 | -- |
|
Exceptional Items
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
13.14 | 138.74 | 6.52 | 8.69 | 3.86 |
|
Provision for Tax
|
3.35 | 31.31 | 1.73 | 0.08 | 1.02 |
|
Profit after Tax
|
9.79 | 107.43 | 4.80 | 8.61 | 2.83 |
Liabilities (₹ Cr)
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
14.73 | 1,724.15 | 32.17 | 30.42 | 10.26 |
|
Minority Interest
|
-- | 46.21 | -- | -- | -- |
|
Non-Current Liabilities
|
7.17 | 72.84 | 0.47 | 2.77 | 4.16 |
|
Current Liabilities
|
16.99 | 845.02 | 24.46 | 6.80 | 11.77 |
|
Total Liabilities
|
39.12 | 2,702.52 | 57.15 | 39.98 | 26.19 |
Assets (₹ Cr)
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
7.81 | 612.51 | 10.70 | 3.56 | 2.93 |
|
Current Assets
|
31.09 | 2,075.71 | 46.40 | 36.42 | 23.26 |
|
Total Assets
|
39.12 | 2,702.52 | 57.15 | 39.98 | 26.19 |
|
Total Debt*
|
15.01 | 298.81 | 21.77 | 5.05 | 11.03 |
|
Net Current Assets
|
14.10 | 1,230.69 | 21.95 | 29.62 | 11.49 |
|
Contingent Liabilities
|
0.05 | 4.01 | 0.39 | -- | 0.77 |
Cashflow (₹ Cr)
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-3.67 | -76.87 | -7.89 | -5.79 | 3.18 |
|
Cash Flow from Investing Activities
|
0.34 | 219.80 | -0.55 | -2.07 | 0.16 |
|
Cash from Financing Activities
|
3.33 | -73.66 | -2.38 | 8.46 | -2.89 |
|
Net Cash Inflow / Outflow
|
0.00 | 69.27 | -10.82 | 0.60 | 0.45 |
Ratios
Profitability Ratios
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
|
ROCE (%)
|
64.18 | 9.16 | 16.08 | 34.47 | 28.82 |
|
ROE (%)
|
99.59 | 6.40 | 14.91 | 37.85 | 39.06 |
|
ROA (%)
|
33.60 | 4.29 | 8.40 | 27.50 | 11.54 |
|
EBIT Margin (%)
|
40.59 | 4.14 | 8.77 | 16.13 | 21.58 |
|
Net Margin (%)
|
25.56 | 2.09 | 4.46 | 14.70 | 10.10 |
|
Cash Profit Margin (%)
|
28.28 | 2.71 | 5.14 | 15.11 | 10.99 |
Growth Ratios
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
150.47 | 29.92 | 0.00 | 111.71 | 19.05 |
|
EBIT Growth (%)
|
170.72 | 67.16 | -- | 73.88 | 40.70 |
|
Net Profit Growth (%)
|
292.00 | 169.94 | 0.00 | 193.43 | 56.94 |
|
EPS Growth (%)
|
292.00 | 142.37 | 0.00 | 133.30 | 56.94 |
|
Book Value Growth (%)
|
198.35 | 5.11 | 0.00 | 101.92 | 39.53 |
Valuation Ratios
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 52.15 | 0.00 | 0.00 | 0.00 |
|
Price / Book Value
|
0.00 | 2.88 | 0.00 | 0.00 | 0.00 |
|
Dividend Yield (%)
|
-- | 0.00 | -- | -- | -- |
|
EV/EBITDA
|
1.56 | 23.61 | 3.49 | 1.13 | 3.06 |
|
Market Cap (₹ Cr)
|
0.00 | 4,944.94 | 0.00 | 0.00 | 0.00 |
Solvency Ratios
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
|
Debt to Equity
|
1.02 | 0.17 | 0.68 | 0.17 | 1.08 |
|
Short term debt to equity ratio
|
0.43 | 0.17 | 0.64 | 0.04 | 0.55 |
|
Current Ratio
|
1.83 | 2.46 | 1.90 | 5.36 | 1.98 |
|
Quick Ratio
|
0.76 | 1.68 | 1.43 | 2.80 | 1.40 |
|
Interest Coverage
|
10.70 | 4.33 | 4.03 | 18.03 | 2.98 |
Operating Efficiency Ratios
| Bio Medica Laboratories | Entero Health | VijayPD Ceutical | Speciality Medicines | Goldline Pharmaceutical | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
10.73 | 16.30 | 22.28 | 16.45 | 38.11 |
|
Asset Turnover
|
1.31 | 2.03 | 1.87 | 1.86 | 1.14 |
|
Receivable days
|
30.75 | 51.78 | 81.32 | 63.57 | 132.15 |
|
Inventory Days
|
121.86 | 38.71 | 39.42 | 79.57 | 92.81 |
|
Payable days
|
117.74 | 24.83 | 8.63 | 14.65 | 64.28 |
|
Cash Conversion Cycle
|
34.88 | 65.66 | 112.12 | 128.49 | 160.68 |
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
